Prophylactic uses of annexin a2
AssigneeThe Regents of the University of Colorado, a body corporate
InventorsZhirui Wang, Ernest Moore
Life of this patent
Estimating the term…
Abstract
Curative and prophylactic therapies for microvascular and/or macrovascular thrombosis are provided, as are prophylactic therapies capable of preventing fibrinolysis shutdown and therapies for non-thrombotic disorders. Methods provide for administering a therapeutically effective amount of an annexin A2.
Claims29
A method of dissolving clot formation in a subject, comprising administering to the subject a therapeutically effective amount of an annexin A2.
A method of treating, preventing, or slowing progression of a non-thrombotic disorder of fibrin deposition in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an annexin A2.
A method of enhancing clot dissolution in a subject, comprising administering to the subject a therapeutically effective amount of an annexin A2.
Dependencies are inferred from the claim text.